Zurueck zur Suche

Reporte zur Charge UT8040NA

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

16Reporte angezeigt
0Todesfaelle
0Hospitalisiert
0Lebensbedrohlich
0Bleibende Schaeden
PA 3 CA 2 MA 2 NM 2 CO 1 AZ 1 WA 1 IN 1 NY 1 ND 1

VAERS 2716220

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge UT8040NA

moderat
Staat
MA
Alter
53,0
Geschlecht
F
Eingang
15.12.2023
Impfdatum
18.09.2023
Beginn
18.09.2023
Tage bis Beginn
0,0
Dosis
1
Route/Site
SYR / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Injected limb mobility decreased Injection site pain Joint range of motion decreased Loss of personal independence in daily activities Pain Periarthritis Product administered at inappropriate site X-ray limb normal

Symptomtext

Pt reported frozen shoulder after vaccine administration on 10/30/2023

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injected limb mobility decreased
Hospital-Tage
-
Labordaten
patient was referred to in PT
Aktuelle Erkrankungen
n/a
Vorgeschichte
n/a
Andere Medikamente
n/a
Allergien
n/a
Vorherige Impfungen
-

VAERS 2693628

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge UT8040NA

moderat
Staat
CO
Alter
58,0
Geschlecht
F
Eingang
10.10.2023
Impfdatum
04.10.2023
Beginn
01.10.2023
Tage bis Beginn
-
Dosis
N/A
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein
Arthralgia Bone pain Injected limb mobility decreased Muscle swelling Underdose X-ray

Symptomtext

When giving customer shot, RN noticed "bumpy" areas on shoulder muscle. She believes she gave shot at appropriate landmarks but became difficult to push last small amount of vaccine in so she stopped and removed needle. Customer started having anterior shoulder pain and clavicle pain following administration of vaccine. Customer felt shot "given too high" (unseen by staff). Customer seen in ER with x-rays performed and given meds to help with pain. Seen by company Occupational Health following ER visit. Customer still unable to move arm higher than waist level and will be seen again by OCC Health first part of next week for further follow up.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injected limb mobility decreased
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
unknown
Vorgeschichte
unknown
Andere Medikamente
unknown
Allergien
unknown
Vorherige Impfungen
-

VAERS 2698254

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge UT8040NA

mild
Staat
AZ
Alter
40,0
Geschlecht
F
Eingang
19.10.2023
Impfdatum
19.09.2023
Beginn
19.09.2023
Tage bis Beginn
0,0
Dosis
N/A
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Arthralgia Loss of personal independence in daily activities Pain Tenderness

Symptomtext

I am still having significant left shoulder pain one month after the administration. The injection was given very high, and I believe was administered into the bursa instead of the muscle. The pain is worse with palpating and lifting my arm up. I can do most activities, but have to take ibuprofen if I know I will be using my arms for a lot of physical activity. I know this will probably heal and recover eventually, but it is impacting my life for now.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Arthralgia
Hospital-Tage
-
Labordaten
None
Aktuelle Erkrankungen
Common Cold
Vorgeschichte
Anxiety, depression, migraines, endometriosis, infertility, eosinophilic esophagitis, Hallux limitus
Andere Medikamente
Escitalopram, Omeprazole, sumatriptan, multivitamin
Allergien
Mineral Oil
Vorherige Impfungen
-

VAERS 2690324

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge UT8040NA

mild
Staat
WA
Alter
5,0
Geschlecht
F
Eingang
03.10.2023
Impfdatum
03.10.2023
Beginn
03.10.2023
Tage bis Beginn
0,0
Dosis
4
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Urticaria

Symptomtext

Approx 10 minutes after flu vaccine, patient developed hives on face. Parents brought back into clinic for examination. No history of allergy to egg or previous immunizations. Received flu vaccine as an infant. On exam patient had several 1-3mm blanching pink wheals on both cheeks and a few on stomach. Not itchy. No facial swelling, tongue or lip swelling, no wheezing or cough. Playful and active. Administered 5mL cetirizine. Instructed to watch closely tonight and to take to ER if worsening rash, any swelling of tongue, lips, or face, or if any wheeze, cough, shortness of breath, or vomiting. Will refer to allergist for skin testing prior to next influenza vaccine.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Urticaria
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2689860

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge UT8040NA

mild
Staat
IN
Alter
2,0
Geschlecht
F
Eingang
03.10.2023
Impfdatum
03.10.2023
Beginn
03.10.2023
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Urticaria

Symptomtext

Patient broke out in hives on face and trunk approximately 5 minutes after vaccine administration. Doctor was immediately notified and evaluated patient reaction. Administered 12.5mg of PO Benadryl. Patient waited in office and was repeatedly checked on by nursing staff and physician.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Urticaria
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
N/A
Allergien
N/A
Vorherige Impfungen
-

VAERS 2689370

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge UT8040NA

mild
Staat
MA
Alter
54,0
Geschlecht
F
Eingang
02.10.2023
Impfdatum
27.09.2023
Beginn
27.09.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja
Lip swelling Rash Rash pruritic Swelling face

Symptomtext

Developed pruritic rash on trunk, limbs, and face, along with swelling of face/lips. Evaluated at urgent care 9/29/2023. Treated with 5 day course of prednisone, along with zyrtec, famotidine.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Rash
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
none
Vorgeschichte
none
Andere Medikamente
none
Allergien
none
Vorherige Impfungen
-

VAERS 2688542

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge UT8040NA

mild
Staat
-
Alter
47,0
Geschlecht
F
Eingang
29.09.2023
Impfdatum
13.09.2023
Beginn
01.09.2023
Tage bis Beginn
-
Dosis
UNK
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Pain Pain in extremity

Symptomtext

Experiencing pain to left arm since vaccine. It hurts to get put on shirts. It hurts to lift left arm. It hurts to rotate left arm for stretching

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pain
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2715395

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge UT8040NA

gering
Staat
NY
Alter
1,1
Geschlecht
M
Eingang
18.11.2023
Impfdatum
03.10.2023
Beginn
24.10.2023
Tage bis Beginn
21,0
Dosis
1
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Inappropriate schedule of product administration No adverse event

Symptomtext

fluzone qiv pfs due to age 13 months. doses were given 3 weeks apart instead of 4 weeks apart with no reported adverse event; Initial information received on 06-Nov-2023 regarding an unsolicited valid non-serious case received from other health professional. This case involves a 13-month-old male patient who was given influenza quadrival A-B vaccine [Fluzone QIV]; 3 weeks apart instead of 4 weeks apart with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On 03-Oct-2023, the patient received unknown Dose 1 of suspect influenza quadrival A-B vaccine, Suspension for injection (Batch number: UT8040NA; Expiry date: 30-Jun-2024) and then on 24-Oct-2023 he again received unknown Dose 2 of the same vaccine (Batch number: UT8134MA; expiry date: 30-Jun-2024) via unknown route in unknown administration site for Immunization; doses were given 3 weeks apart instead of 4 weeks apart with no reported adverse event (inappropriate schedule of product administration) (same day latency). Reportedly, Pt needed a 2 dose series of FLUZONE QIV PFS due to age 13 months. Doses were given 3 weeks apart instead of 4 weeks apart. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Inappropriate schedule of product administration
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2703728

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge UT8040NA

gering
Staat
CA
Alter
0,6
Geschlecht
F
Eingang
27.10.2023
Impfdatum
19.10.2023
Beginn
19.10.2023
Tage bis Beginn
0,0
Dosis
2
Route/Site
IM / RL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Inappropriate schedule of product administration

Symptomtext

Patient received a booster dose of flu at the incorrect interval. Patient should have received the second booster dose at a 4-week interval, but the patient received it at a 3-week interval.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Inappropriate schedule of product administration
Hospital-Tage
-
Labordaten
N/A
Aktuelle Erkrankungen
N/A
Vorgeschichte
N/A
Andere Medikamente
N/A
Allergien
N/A
Vorherige Impfungen
-

VAERS 2697178

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge UT8040NA

gering
Staat
CA
Alter
0,7
Geschlecht
F
Eingang
17.10.2023
Impfdatum
13.10.2023
Beginn
13.10.2023
Tage bis Beginn
0,0
Dosis
3
Route/Site
IM / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Extra dose administered

Symptomtext

The patient received a 3rd dose of flu and was not due for an additonal dose of flu until next years flu season. One 09/07/2023 Second 10/09/2023 Third 10/13/2023

Weitere VAERSDATA-Felder
Praegender Schweregrund
Extra dose administered
Hospital-Tage
-
Labordaten
N/A
Aktuelle Erkrankungen
N/A
Vorgeschichte
Respiratory Laryngopharyngeal reflux (LPR) Digestive Congenital ankyloglossia Musculoskeletal Plagiocephaly Other Poor feeding of newborn Slow weight gain in pediatric patient Neonatal difficulty in feeding at breast Feeding problem Gassiness Abnormal stools
Andere Medikamente
Malarone, 62.5-25mg, 1/2 tab daily Ergocalciferol, 0.25ml daily Lactobillus 5 drops daily Nexium Packet, 5gm 1 packet daily
Allergien
N/A
Vorherige Impfungen
-

VAERS 2696283

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge UT8040NA

gering
Staat
NM
Alter
44,0
Geschlecht
F
Eingang
15.10.2023
Impfdatum
10.10.2023
Beginn
10.10.2023
Tage bis Beginn
0,0
Dosis
2
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Extra dose administered Wrong product administered

Symptomtext

Influenza vaccine administered instead of Tdap on 10/10/2023. Recently received quad influenza vaccine on 10/2/2023.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Extra dose administered
Hospital-Tage
-
Labordaten
na
Aktuelle Erkrankungen
na
Vorgeschichte
Anxiety, depression, hypertension, Barretts esophagus, hypothyroidism, rheumatoid arthritis, sclerosis
Andere Medikamente
potassium chloride, lisinopril, Maxzide, amlodipine, levothyroxine, mycophenolate, ergocalciferol, folic acid, Vistaril, fluoxetine, buspirone, omeprazole
Allergien
Keflex, Bactrim.
Vorherige Impfungen
-

VAERS 2694772

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge UT8040NA

gering
Staat
NM
Alter
53,0
Geschlecht
F
Eingang
12.10.2023
Impfdatum
05.10.2023
Beginn
05.10.2023
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Product administered to patient of inappropriate age

Symptomtext

High dose flu vaccine administered instead of Fluzone Quad.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product administered to patient of inappropriate age
Hospital-Tage
-
Labordaten
na
Aktuelle Erkrankungen
na
Vorgeschichte
Brachial neuritis, Sjogren syndrome, fibromyalgia, lupus, GERD, rhinosinusitis, type 2 diabetes, hypertension, obesity
Andere Medikamente
amitriptyline, gabapentin, hydrochlorothiazide, hydroxychloroquine, metformin, rosuvastatin, sarilumab, Ozempic, tizanidine, Percocet
Allergien
methotrexate
Vorherige Impfungen
-

VAERS 2687258

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge UT8040NA

gering
Staat
ND
Alter
-
Geschlecht
M
Eingang
27.09.2023
Impfdatum
27.09.2023
Beginn
27.09.2023
Tage bis Beginn
0,0
Dosis
2
Route/Site
IM / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Inappropriate schedule of product administration No adverse event

Symptomtext

Appointment scheduled too early for 2nd dose of Influenza. Computer scanner was not working and nurse waiting for restart of computer and scanner. All questions asked of mother while waiting for computer. Influenza dose administered before scanner available. 2nd dose of Influenza was too early for vaccine schedule. No negative outcomes reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Inappropriate schedule of product administration
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2686324

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge UT8040NA

gering
Staat
PA
Alter
36,0
Geschlecht
F
Eingang
26.09.2023
Impfdatum
14.09.2023
Beginn
14.09.2023
Tage bis Beginn
0,0
Dosis
1
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Exposure during pregnancy No adverse event

Symptomtext

Vaccine exposure during pregnancy with no reported adverse event; Initial information received on 14-Sep-2023 regarding an unsolicited valid non-serious case received from other health professional. This case involves a 36-years-old female patient who was exposed to influenza quadrival A-B vaccine [Fluzone Quadrivalent] during pregnancy with no reported adverse event. The date of last menstrual period was reported as 18-Jul-2023. The estimated due date is 28-Apr-2024. The patient's past medical treatment(s), vaccination(s) and family history were not provided. It is unknown if the patient had any medical history, concomitant disease or risk factor. On 14-Sep-2023, the patient received unknown Dose 1 of suspect influenza quadrival A-B vaccine, suspension for injection (batch number: UT8040NA; expiry date unknown) via intramuscular route in unknown administration site for prophylactic vaccination (immunization) during pregnancy with no reported adverse event (exposure during pregnancy) (same day latency). It is unknown if there were lab data/results available. Action taken: not applicable. At time of reporting, the outcome was Unknown for the event. Additionally, at time of reporting, the pregnancy is still ongoing.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Exposure during pregnancy
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2679570

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge UT8040NA

gering
Staat
PA
Alter
24,0
Geschlecht
F
Eingang
06.09.2023
Impfdatum
31.08.2023
Beginn
31.08.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Exposure during pregnancy

Symptomtext

Fluzone exposure during pregnancy, with no reported adverse event; Initial information received on 31-Aug-2023 regarding an unsolicited valid non-serious case received from other health professional. This case involves a 24 years old pregnant female patient who was exposed to vaccine Influenza Quadrival A-B Vaccine Preserved [Fluzone Quadrivalent] with no reported adverse event. Data regarding this pregnancy were received prospectively, i.e. before pregnancy outcome was known. The reported Fluzone exposure during pregnancy, with no reported adverse event occurred at 9 weeks of pregnancy and the patient was exposed Influenza Quadrival A-B Vaccine Preserved at 9 weeks of pregnancy, during first pregnancy trimester for Influenza Quadrival A-B Vaccine Preserved. The date of last menstrual period was reported as 13-Jul-2023. The estimated due date is 13-Apr-2024. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. The patient had unknown previous pregnancy/ies. On 31-Aug-2023, the pregnant patient received an unknown dose of suspect Influenza Quadrival A-B Multidose Vaccine Preserved (exposure during pregnancy) (latency: same day) (strength: unknown , expiry date: Jun-2024, lot UT8040NA) via intramuscular route in the G. deltoid NOS (Not otherwise specified) as Influenza immunization. Action taken: not applicable. At time of reporting, the outcome was Unknown for the event. Additionally, at time of reporting, the pregnancy is still ongoing.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Exposure during pregnancy
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2679451

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge UT8040NA

gering
Staat
PA
Alter
35,0
Geschlecht
F
Eingang
06.09.2023
Impfdatum
31.08.2023
Beginn
31.08.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Exposure during pregnancy No adverse event

Symptomtext

maternal vaccine exposure with no reported adverse event; Initial information received on 31-Aug-2023 regarding an unsolicited valid non-serious case received via other health professional. This case involves a 35-year-old female patient who was exposed to vaccine influenza quadrival A-B vaccine [Fluzone Quadrivalent] in context of maternal vaccine exposure with no reported adverse event. Data regarding this pregnancy were received prospectively. The reported maternal vaccine exposure with no reported adverse event occurred at unknown gestation period. The date of last menstrual period was not reported. The estimated due date is 31-Oct-2023. The patient's past medical history, medical treatment(s), vaccination(s), concomitant(s) and family history were not provided. The patient had unknown previous pregnancy/ies. On 31-Aug-2023, the patient received an unknown dose of suspect influenza quadrival A-B vaccine suspension for injection (strength: unknown) (lot: UT8040NA, expiry date: Jun-2024) via intramuscular route in unknown administration site for prophylactic vaccination (immunization) and patient had maternal vaccine exposure with no reported adverse event (maternal exposure timing unspecified) (latency: same day). It was unknown if any lab data/test results available. Action taken with quadrivalent influenza vaccine (Fluzone Quadrivalent) was not applicable. Outcome: Unknown. Additionally, at time of reporting, the pregnancy was still ongoing.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Exposure during pregnancy
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-